Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Teal Valley T.TV


Primary Symbol: P.TEAL

Teal is a Canadian, pharmaceutical & NHP manufacturer selling to Canada’s national, chain drug stores, presently expanding its portfolio to include cannabinoid-based products utilizing proprietary formulations & extractions for both the global Rx & recreational markets.


P.TEAL - Post by User

Post by Namehijeron Nov 11, 2021 12:45pm
184 Views
Post# 34115590

What I'm expecting on the call

What I'm expecting on the callAnnouncememt during it or in next week --hedging transaction.
Expanded credit facility.
News on Caribou and satellite deposit and quantification of potential.
Plan for Perkoa.
Funding decision on RP 2.0 and updated timeline.

If management doesn't accept cheap buyout, I expect this to return to new highs or greater heights in the next 2 years. Of course, I expect zinc to be at $2 before the end of this time frame as well--by the end of 2023. Dollar decline like last time it skyrocketed. 2.5 wouldn't surprise me. Hell maybe $3.

Time will tell. 

Of course, I'm still trying to figure out how they went from 90 cent target for AISC to 94-98 cents --with a windfall of 6 cents AISC from treatment charge benefits vs the 225 treatment charge they had assumed.. Their 90 cent target must have been overly aggressive. Hopefully, they don't pull a major blackhole in projecting next year  in sitting cost guidance. Stock price will be  partially dependent on them hitting their guidance next year--hopefully they llearned from this year. Huge miss on guidance in 2021.
<< Previous
Bullboard Posts
Next >>